Início › Câncer de Ovário › Califórnia › San Diego
Ensaios clínicos de Câncer de Ovário em San Diego, CA
24 estudos para Câncer de Ovário estão buscando participantes em locais em San Diego e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
RecrutandoFase 2
- Scripps Md Anderson - Prebys Cancer Center /ID# 276891, San Diego
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
RecrutandoFase 2
- UC San Diego Health - Moores Cancer Center /ID# 277574, La Jolla · a 11 mi de distância
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecrutandoFase 2
- UC San Diego Medical Center - Hillcrest, San Diego
- Sharp Memorial Hospital, San Diego
- UC San Diego Moores Cancer Center, La Jolla · a 11 mi de distância
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecrutandoFase 1/2
- University of San Diego Moores Cancer Center, La Jolla · a 11 mi de distância
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RecrutandoFase 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · a 11 mi de distância
DESTINY-PANTUMOUR04
RecrutandoEstudo observacional
- Research Site, San Diego
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RecrutandoEstudo observacional
- University of California San Diego, La Jolla · a 11 mi de distância
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RecrutandoFase 3
- Moores Cancer Center, La Jolla · a 11 mi de distância
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RecrutandoFase 3
- University of California, San Diego-Moores Cancer Center, La Jolla · a 11 mi de distância
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RecrutandoFase 2
- Scripps Healthscripps Mercy Hospital Prebys Cancer Center, San Diego
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RecrutandoEstudo observacional
- University of California, San Diego, La Jolla · a 11 mi de distância
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
RecrutandoFase 2
- UC San Diego Health, La Jolla · a 11 mi de distância
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RecrutandoFase 1
- Scripps Health, San Diego
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
RecrutandoFase 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · a 11 mi de distância
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
RecrutandoFase 1
- UC San Diego Moores Cancer Center, La Jolla · a 11 mi de distância
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
RecrutandoFase 3
- UC San Diego Health - Moores Cancer Center, La Jolla · a 11 mi de distância
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecrutandoFase 3
- Kaiser Permanente-San Diego Zion, San Diego
- UC San Diego Moores Cancer Center, La Jolla · a 11 mi de distância
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecrutandoFase 1/2
- University of California, San Diego; Moores Cancer Center, San Diego
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
RecrutandoFase 1
- Investigative Site #101, La Jolla · a 11 mi de distância
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
RecrutandoFase 3
- Scripps Clinic, La Jolla · a 11 mi de distância
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RecrutandoFase 1/2
- UCSD Moores Cancer Center, La Jolla · a 11 mi de distância
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
RecrutandoFase 3
- University of California San Diego Moores Cancer Center, La Jolla · a 11 mi de distância
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, La Jolla · a 11 mi de distância
A Beta-only IL-2 ImmunoTherapY Study
RecrutandoFase 1/2
- Sharp Memorial Hospital, San Diego
Ensaios de Câncer de Ovário em outras cidades
- Houston, TX89 estudos
- New York City, NY70 estudos
- Boston, MA61 estudos
- Los Angeles, CA50 estudos
- Nashville, TN49 estudos
- Arlington, VA46 estudos
- Philadelphia, PA45 estudos
- Columbus, OH39 estudos
- St. Louis, MO38 estudos
- Chicago, IL36 estudos
- Pittsburgh, PA31 estudos
- San Antonio, TX31 estudos
Outros estudos em San Diego
- Câncer de Pulmão de Não Pequenas Células48 estudos
- Câncer de Mama42 estudos
- Câncer (todos os tipos)32 estudos
- Câncer de Próstata31 estudos
- Câncer Metastático30 estudos
- Câncer Colorretal25 estudos
- Câncer de Pâncreas24 estudos
- Insuficiência Cardíaca23 estudos
- Obesidade23 estudos
- Câncer de Pulmão23 estudos
- Depressão21 estudos
- Melanoma18 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 7 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.